类风湿关节炎患者心血管风险与死亡率:与糖尿病及一般人群的比较
该研究将新诊断类风湿关节炎(RA)患者按年龄、性别和诊断年份与一般人群1:5匹配,并纳入同期新诊断糖尿病(DM)患者,比较诊断后10年内心力衰竭、心肌梗死、冠脉血运重建、卒中、主要不良心血管事件(MACE)及死亡风险。结果显示RA患者上述心血管风险高于一般人群,但未达到DM患者的水平;RA 10年全因死亡率与一般人群相当,DM患者10年死亡率、心源性死亡及MACE风险最高。
要点
- RA患者心衰、心梗、冠脉血运重建和卒中风险高于一般人群。
- RA患者心衰、CABG和卒中风险低于DM患者,心梗和PCI风险与DM相近。
- RA 10年全因死亡率与一般人群相当,DM患者死亡及MACE风险最高。
核心结论
- RA患者心血管疾病风险高于一般人群,但未达到DM患者的风险水平。
- RA患者10年全因死亡率与一般人群相当,DM患者10年死亡率、心源性死亡和MACE风险最高。
研究设计与样本
- 纳入新诊断RA患者15 032例,按年龄、性别和RA诊断年份与一般人群1:5匹配。
- 同期纳入新诊断DM患者301 246例和一般人群75 160人。
- 观察诊断后10年内心衰、心梗、冠脉血运重建、卒中、MACE和死亡结局。
主要发现
- 与一般人群相比,RA患者心衰风险HR 1.51(95% CI:1.38,1.64),心梗HR 1.58(95% CI:1.43,1.74)。
- 与一般人群相比,RA患者PCI风险HR 1.44(95% CI:1.27,1.62),CABG风险HR 1.30(95% CI:1.05,1.62),卒中风险HR 1.22(95% CI:1.12,1.33)。
- 与DM患者相比,RA患者心衰风险HR 0.79(95% CI:0.73,0.85),CABG风险HR 0.62(95% CI:0.51,0.76),卒中风险HR 0.82(95% CI:0.76,0.89),心梗和PCI风险相近。
- RA患者10年全因死亡率与一般人群处于同一水平,心源性死亡和MACE较一般人群增加。
- DM患者10年死亡率、心源性死亡和MACE风险最高。
关键数值与推荐
- RA与一般人群比较:心衰HR 1.51(95% CI:1.38,1.64),心梗HR 1.58(95% CI:1.43,1.74),PCI HR 1.44(95% CI:1.27,1.62),CABG HR 1.30(95% CI:1.05,1.62),卒中HR 1.22(95% CI:1.12,1.33)。
- RA与DM比较:心衰HR 0.79(95% CI:0.73,0.85),CABG HR 0.62(95% CI:0.51,0.76),卒中HR 0.82(95% CI:0.76,0.89)。
临床怎么用
- 对RA患者应关注心衰、心梗、卒中和冠脉血运重建风险,并将其心血管风险管理纳入长期随访。
- RA患者心血管风险虽低于DM患者,但10年全因死亡率与一般人群相当,仍需重视心源性死亡和MACE的监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To compare risk of cardiovascular disease and mortality in patients with incident RA, diabetes mellitus (DM) and the general population (GP). METHODS: Patients diagnosed with incident RA were matched 1:5 by age, sex and year of RA diagnosis with the GP. In the same period, patients with incident DM were included. Outcomes were heart failure (HF), myocardial infarction (MI), coronary revascularization, stroke, major adverse cardiovascular events (MACE) and death up to 10 years after diagnosis. RESULTS: We included 15 032 patients with incident RA, 301 246 patients with DM and 75 160 persons from the GP. RA patients had an increased risk of HF [hazard ratio (HR) 1.51, 95% CI: 1.38, 1.64], MI (HR 1.58, 95% CI: 1.43, 1.74), percutaneous coronary intervention (PCI; HR 1.44, 95% CI: 1.27, 1.62), coronary artery bypass grafting (CABG; HR 1.30, 95% CI: 1.05, 1.62) and stroke (HR 1.22, 95% CI: 1.12-1.33) compared with the GP. However, the 10-year all-cause mortality was at the same level as observed in the GP. Cardiac death and MACE were increased in RA compared with the GP. When compared with patients with DM, RA patients had a lower adjusted risk of HF (HR 0.79, 95% CI: 0.73, 0.85), CABG (HR 0.62, 95% CI: 0.51, 0.76) and stroke (HR 0.82, 95% CI: 0.76, 0.89), and similar risk of MI and PCI. DM patients had the highest risk of 10-year mortality, cardiac death and MACE. CONCLUSION: This study demonstrates that RA is associated with an increased risk of HF, MI, stroke and coronary revascularization than found in the GP but without reaching the risk levels observed in DM patients.
引用
- Løgstrup BB, Ellingsen T, Pedersen AB, et al. Cardiovascular risk and mortality in rheumatoid arthritis compared with diabetes mellitus and the general population. Rheumatology (Oxford). 2021. PMID: 32984893. doi:10.1093/rheumatology/keaa374
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。